These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25851286)

  • 21. Molecular aspects of T- and B-cell function in uremia.
    Girndt M; Sester M; Sester U; Kaul H; Köhler H
    Kidney Int Suppl; 2001 Feb; 78():S206-11. PubMed ID: 11169012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Essential amino acids supplementation therapy in uremic patients with regular dialysis treatment].
    Ando A
    Nihon Rinsho; 1991 Dec; 49 Suppl():775-80. PubMed ID: 1808349
    [No Abstract]   [Full Text] [Related]  

  • 23. ["Malnutrition-inflammation complex syndrome" in chronic hemodialysis].
    Young P; Lombi F; Finn BC; Forrester M; Campolo-Girard V; Pomeranz V; Iriarte R; Bruetman JE; Trimarchi H
    Medicina (B Aires); 2011; 71(1):66-72. PubMed ID: 21296726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant neoplasms in long-term hemodialysis patients.
    Olusegun Fayemi A; Ali M
    J Med Soc N J; 1979 Jul; 76(7):497-500. PubMed ID: 289847
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic alterations associated with chronic hemodialysis.
    Rus HG; Cristea A; Gherman M; Niculescu F; Gavan M
    Med Interne; 1983; 21(4):289-95. PubMed ID: 6658343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of heart failure in long-term dialysis patients: a reappraisal.
    Wang AY; Sanderson JE
    Am J Kidney Dis; 2011 May; 57(5):760-72. PubMed ID: 21349619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of acetate and bicarbonate on the tolerance for hemodialysis therapy in chronic kidney failure].
    Shostka GD; T'iagi S; Kulikova AI; Spiridonov VN; Kostkina MI; Vitenberg AG
    Urol Nefrol (Mosk); 1990; (6):39-44. PubMed ID: 2089765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amelioration of uremic tumoral calcinosis with high-flux hemodialysis treatment.
    Xie T; Zhang Y; Tang X; Chen M; Zhang W
    Int Urol Nephrol; 2014 Jul; 46(7):1467-8. PubMed ID: 24595601
    [No Abstract]   [Full Text] [Related]  

  • 30. Outcome of End-Stage Renal Disease Patients with Advanced Uremia and Acidemia.
    Rehman IU; Idrees MK; Shoukat
    J Coll Physicians Surg Pak; 2016 Jan; 26(1):31-5. PubMed ID: 26787028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dialysis prescription and kinetics in acute renal failure.
    Clark WR; Mueller BA; Kraus MA; Macias WL
    Adv Ren Replace Ther; 1997 Apr; 4(2 Suppl 1):64-71. PubMed ID: 9113242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uremia Retention Molecules and Clinical Outcomes.
    Barreto FC; Barreto DV; Canziani MEF
    Contrib Nephrol; 2017; 191():18-31. PubMed ID: 28910788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vitamin D and survival of hemodialysis patients].
    Shoji T; Nishizawa Y
    Clin Calcium; 2004 Sep; 14(9):64-8. PubMed ID: 15577113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress and inflammation: Implications in uremia and hemodialysis.
    Libetta C; Sepe V; Esposito P; Galli F; Dal Canton A
    Clin Biochem; 2011 Oct; 44(14-15):1189-98. PubMed ID: 21777574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot investigation of cognitive improvement across a single hemodialysis treatment.
    Cukor D; Ver Halen N; Rosenthal Asher D; Goldberg MA; Slyker J; Kimmel PL
    J Nephrol; 2013; 26(2):323-30. PubMed ID: 22684651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic systemic inflammation in dialysis patients: an update on causes and consequences.
    Yao Q; Axelsson J; Stenvinkel P; Lindholm B
    ASAIO J; 2004; 50(6):lii-lvii. PubMed ID: 15672781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.
    Soyoral YU; Demir C; Begenik H; Esen R; Kucukoglu ME; Aldemir MN; Demirkiran D; Erkoc R
    Clin Appl Thromb Hemost; 2012; 18(2):185-8. PubMed ID: 22327827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dialysis disequilibrium syndrome and other treatment complications of extreme uremia: a rare occurrence yet not vanished.
    Lopez-Almaraz E; Correa-Rotter R
    Hemodial Int; 2008 Jul; 12(3):301-6. PubMed ID: 18638082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. More of the same: improving outcomes through intensive hemodialysis.
    McFarlane PA
    Semin Dial; 2009; 22(6):598-602. PubMed ID: 20017828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.